Avesthagen
 |
Business: Research in biotechnology, nutrition and healthcare
Biotech Revenue: Rs 16 crore
CEO: Dr Villoo Morawala-Patell (Vice Chairperson and MD)
Start-up Year: 1988
Address: "Discoverer", 9th Floor, International Tech Park, Whitefield Road, Bangalore - 560 066
Tel.: 91-80-2841 1877
Fax: 91-80-2841 8780
Website: www.avesthagen.com
Avesthagen, founded in 1998, is a science and discovery based
life sciences company that focuses on achieving convergence between food, pharma
and population genetics leading to preventive personalized medicine. To this end
the company develops, both in-house and/or in partnering mode, medicinal plant
based bioactive nutraceuticals for degenerative conditions ("Food for
Medicine" program), such as diabetes, obesity, osteoporosis and CVD,
biopharmaceuticals, DNA based diagnostic products allowing for future
personalized therapies (e.g. tuberculosis), and novel, value-added seed hybrids
combining abiotic stress tolerance with enhanced nutritional value ("Seed
for Food" program). Avesthagen also uses its technology platform and
capabilities to provide innovative R&D services to the global pharma,
biotech, food and seed industries ("RPO – Research Process
Outsourcing"
program).
Avesthagen is about to start construction of its new facilities, which will include additional facilities such as cGMP facilities for pilot and commercial scale manufacturing of biopharmaceuticals, P3 labs for research on emerging pathogens, pilot scale plant extraction facilities as well as facilities for animal trials.
It recently launched Avestagenome, a unique project to build a complete genetic, genealogical and medical database of the Parsis. This Rs 125-crore project is expected to be completed within five years.
